Design, Synthesis, and Evaluation of Pharmacological Properties of Cinnamic Derivatives as Antiatherogenic Agents

Journal of Medicinal Chemistry
2005.0

Abstract

A series of cinnamic and phosphonocinnamic derivatives have been synthesized and their ability to inhibit cell-mediated LDL oxidation and oxidized LDL-induced cytotoxicity was investigated. Electron-donating substituents surrounding the necessary 4-OH group of the aromatic ring showed the best results. Among the different series tested, amide 1, thioester 5c, phosphonoester 7c, and the fluorophosphonocinnamic analogue 12c exhibited a potent inhibitory effect against LDL oxidation (and subsequent toxicity) mediated by cultured human microvascular endothelial cells (HMEC-1), with an efficacy comparable to that observed with probucol. Beside this indirect protective effect, these compounds exhibited a direct protective effect against the toxicity of previously oxidized LDL in HMEC-1. These data suggest that the newly synthesized cinnamic compounds should protect against early events (cell-mediated LDL oxidation) occurring within the vascular wall in atherosclerosis.

Knowledge Graph

Similar Paper

Design, Synthesis, and Evaluation of Pharmacological Properties of Cinnamic Derivatives as Antiatherogenic Agents
Journal of Medicinal Chemistry 2005.0
Antioxidant activity of benzoxazolinonic and benzothiazolinonic derivatives in the LDL oxidation model
Bioorganic & Medicinal Chemistry 2009.0
Inhibition of LDL oxidation and inflammasome assembly by nitroaliphatic derivatives. Potential use as anti-inflammatory and anti-atherogenic agents
European Journal of Medicinal Chemistry 2018.0
Ligustrazine derivatives. Part 5: Design, synthesis and biological evaluation of novel ligustrazinyloxy-cinnamic acid derivatives as potent cardiovascular agents
European Journal of Medicinal Chemistry 2011.0
A Novel Series of 2,6,7-Substituted 2,3-Dihydro-1,4-Benzodioxin and 2,6,7-Substituted 1,4-Benzodioxin Derivatives as Lipid Peroxidation Inhibitors. Structure−Activity Relationships for High Inhibition of Human Low-Density Lipoprotein Peroxidation
Journal of Medicinal Chemistry 2001.0
Development of Novel Antiatherogenic Biaryls: Design, Synthesis, and Reactivity
Journal of Medicinal Chemistry 2008.0
Dual antioxidant structures with potent anti-inflammatory, hypolipidemic and cytoprotective properties
Bioorganic & Medicinal Chemistry Letters 2017.0
Design, synthesis and biological evaluation of novel trimethylpyrazine-2-carbonyloxy-cinnamic acids as potent cardiovascular agents
MedChemComm 2014.0
Design, synthesis and biological evaluation of novel ligustrazinylated derivatives as potent cardiovascular agents
MedChemComm 2013.0
Phenothiazines as lipid peroxidation inhibitors and cytoprotective agents
Journal of Medicinal Chemistry 1992.0